Skip to main content
. 2010 Apr 1;15(4):2374–2387. doi: 10.3390/molecules15042374

Table 1.

Clinico-pathological information of OSCC patients.

Varible Group Cases (%)
Gender
(n = 142)
Male
Female
112 (78.9)
30 (21.1)
Race
(n = 142)
Caucasians
Others
122 (85.9)
20 (14.1)
Tabacco
(n = 142)
No
Light
Moderate/Severe
Ignored
15 (10.6)
99 (69.7)
17 (12)
11 (7.7)
Alcohol
(n = 142)
No
Light
Moderate/Severe
Ignored
27 (19.0)
89 (62.7)
15 (10.6)
11 (7.7)
Site
(n = 142)
Tongue
Gingiva
Floor of the mouth
Palate
Jugal
Retromolar
54 (38)
20 (14.1)
42 (29.6)
1 (0.7)
6 (4.2)
19 (13.4)
Vascular Invision
(n = 142)
No observed
Yes
Ignored
75 (52.8)
53 (37.3)
14 (9.9)
Clinic Stage
(n = 142)
I/II
III/IV
37 (26.1)
105 (73.9)
Recurrence
(n = 142)
No
Yes
92 (64.8)
50 (35.2)
Site of Recurrence
(n = 142)
Local
Others
Local/others
No recurrence
41 (28.8)
7 (4.9)
2 (1.4)
92 (64.8)
Status of last contact
(n = 142)
Alive wth disease
Alive wthout disease
Death due to disease
Death due to other causes
Lost
2 (1.4)
61 (43)
45 (31.7)
26 (18.3)
8 (5.6)